The ALRCaN Global webinar, “Incorporating Immunotherapy Into Upfront Ph-Negative Acute Lymphoblastic Leukemia Therapy,” is set for Friday, May 15, 2026, from 09:00 AM to 10:00 AM ET (05:00 PM – 06:00 PM AMT).

Led by Dr. Mark Litzow, this session explores the evolving treatment landscape and clinical integration of immunotherapeutic agents into frontline regimens for patients with Philadelphia chromosome-negative Acute Lymphoblastic Leukemia. Organized by the Acute Leukemia Research and Care Network (ALRCaN) and Resonance Health, and supported by Scott Howard, Stacy Cooper, Archie Bleyer, and Dan Douer, this forum provides a platform for experts to discuss novel therapeutic combinations and the optimization of outcomes in upfront leukemia management.